EichorEICHOR
Study identifier: NCT06024746 Synced from ClinicalTrials.gov · August 05, 2026
● Recruiting

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)

Condition: Heart Failure  ·  Sponsor: Colorado Prevention Center

PhasePhase 3
Planned participants1500
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Combination therapy of finerenone plus empagliflozin will be compared to usual care to determine the efficacy and safety of treatment in patients hospitalized with heart failure.

This description comes directly from the study's public registry record.

Talk to the study team

Marc Bonaca  ·  (303) 860-9900  ·  info@cpcmed.org

Always discuss trial participation with your own doctor first.

Locations (104)

CON-10004 Fairhope, AL Investigational SiteFairhope, Alabama, United StatesRecruiting
CON-10075 El Centro, CA Investigational SiteEl Centro, California, United StatesRecruiting
CON-10024 Sacramento, CA Investigational SiteSacramento, California, United StatesRecruiting
CON-10023, San Francisco, CASan Francisco, California, United StatesRecruiting
CON-10109, Van Nuys, CAVan Nuys, California, United StatesRecruiting
CON-10001, Aurora, COAurora, Colorado, United StatesRecruiting
CON-10005, Denver, CODenver, Colorado, United StatesRecruiting
CON-10078, Hialeah, FLHialeah, Florida, United StatesRecruiting
CON-10105, Miami, FLMiami, Florida, United StatesRecruiting
CON-10113, Miramar, FLMiramar, Florida, United StatesRecruiting
CON-10022 Atlanta, GA Investigational SiteAtlanta, Georgia, United StatesRecruiting
CON-10021, Glenview, ILGlenview, Illinois, United StatesRecruiting

+ 92 more locations — full list on the registry record.

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06024746